Literature DB >> 8431712

Rebound thymic hyperplasia following high dose chemotherapy and allogeneic BMT.

R Miniero1, A Busca, E Leonardo, C Mossetti, D Machado, E Vassallo, E Madon.   

Abstract

We describe a child with acute lymphoblastic leukemia who showed mediastinal widening 8 months after allogeneic BMT. Total thymectomy was carried out by the transcervical approach. Histologic examination showed only thymic hyperplasia. The immunohistologic investigation revealed a normal distribution of thymic cell elements, without evidence of clonal proliferation of lymphocytic subpopulations. This case supports the hypothesis that thymic hyperplasia following chemotherapy may be merely a rebound phenomenon. The patient had an uneventful postoperative recovery and remains in remission more than 1 year after BMT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431712

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  1 in total

Review 1.  [Chemotherapy definitions and policies for thymic malignancies].

Authors:  Nicolas Girard; Rohit Lal; Heather Wakelee; Gregory J Riely; Patrick J Loehrer
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.